FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37503511000001101: Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
349471000001118 Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
349481000001116 Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely ciprofloxacin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Is a Ciproxin true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Ciprofloxacin true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 100 ml Has AMP True Ciproxin 250mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start